Previous Article | Next Article 
J Virol. 1990 March; 64(3): 1278-1282
Sequence variants of human T-cell lymphotropic virus type I from patients with tropical spastic paraparesis and adult T-cell leukemia do not distinguish neurological from leukemic isolates.
S Daenke,
S Nightingale,
J K Cruickshank and
C R Bangham
Institute for Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom.
ABSTRACT
We have amplified and sequenced DNA in the envelope (env) and long terminal repeat (LTR) regions of human T-cell lymphotropic virus type I (HTLV-I) proviruses from the peripheral blood of 10 HTLV-I-seropositive patients with tropical spastic paraparesis (TSP) and two patients with adult T-cell leukemia. The aim was to examine variation in these regions and to test the hypothesis that the sequences of leukemogenic HTLV-I isolates differ from those causing the neurological disease TSP. In 5 of the 12 HTLV-I-seropositive patients, more than one HTLV-I sequence variant was identified in the same individual. No two individuals shared identical sequences in either env or LTR U3. Sequence variations were found at 73 positions in 1,416 bases amplified in env. Sequence variability was found throughout the LTR-U3 region, including the sequences of two transcriptional enhancers. Several nucleotide changes common to both Caribbean and Japanese HTLV-I isolates allowed us to identify a consensus sequence that differs from the HTLV-I prototype sequence (M. Seiki, S. Hattori, Y. Hirayama, and M. Yoshida, Proc. Natl. Acad. Sci. USA 80:3618-3622, 1983). No sequence in the env or LTR U3 region was found to be characteristic of isolates from TSP patients. Although each isolate was distinct at the nucleotide level, the predicted protein sequence of HTLV-I env is less variable than that of human immunodeficiency virus env, suggesting that these lymphotropic retroviruses use different strategies to evade host immune responses.
J Virol. 1990 March; 64(3): 1278-1282
This article has been cited by other articles:
-
Takayanagi, R., Ohashi, T., Yamashita, E., Kurosaki, Y., Tanaka, K., Hakata, Y., Komoda, Y., Ikeda, S., Tsunetsugu-Yokota, Y., Tanaka, Y., Shida, H.
(2007). Enhanced Replication of Human T-Cell Leukemia Virus Type 1 in T Cells from Transgenic Rats Expressing Human CRM1 That Is Regulated in a Natural Manner. J. Virol.
81: 5908-5918
[Abstract]
[Full Text]
-
Silverman, L. R., Phipps, A. J., Montgomery, A., Fernandez, S., Tsukahara, T., Ratner, L., Lairmore, M. D.
(2005). In vivo analysis of replication and immunogenicity of proviral clones of human T-lymphotropic virus type 1 with selective envelope surface-unit mutations. Blood
106: 3602-3608
[Abstract]
[Full Text]
-
Nomura, M., Ohashi, T., Nishikawa, K., Nishitsuji, H., Kurihara, K., Hasegawa, A., Furuta, R. A., Fujisawa, J.-i., Tanaka, Y., Hanabuchi, S., Harashima, N., Masuda, T., Kannagi, M.
(2004). Repression of Tax Expression Is Associated both with Resistance of Human T-Cell Leukemia Virus Type 1-Infected T Cells to Killing by Tax-Specific Cytotoxic T Lymphocytes and with Impaired Tumorigenicity in a Rat Model. J. Virol.
78: 3827-3836
[Abstract]
[Full Text]
-
Hasegawa, A., Ohashi, T., Hanabuchi, S., Kato, H., Takemura, F., Masuda, T., Kannagi, M.
(2003). Expansion of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Reservoir in Orally Infected Rats: Inverse Correlation with HTLV-1-Specific Cellular Immune Response. J. Virol.
77: 2956-2963
[Abstract]
[Full Text]
-
Ohashi, T., Hanabuchi, S., Suzuki, R., Kato, H., Masuda, T., Kannagi, M.
(2002). Correlation of Major Histocompatibility Complex Class I Downregulation with Resistance of Human T-Cell Leukemia Virus Type 1-Infected T Cells to Cytotoxic T-Lymphocyte Killing in a Rat Model. J. Virol.
76: 7010-7019
[Abstract]
[Full Text]
-
Tajima, S., Aida, Y.
(2000). The Region between Amino Acids 245 and 265 of the Bovine Leukemia Virus (BLV) Tax Protein Restricts Transactivation Not Only via the BLV Enhancer but Also via Other Retrovirus Enhancers. J. Virol.
74: 10939-10949
[Abstract]
[Full Text]
-
Bangham, C. R M
(2000). HTLV-1 infections. J. Clin. Pathol.
53: 581-586
[Abstract]
[Full Text]
-
Ohashi, T., Hanabuchi, S., Kato, H., Koya, Y., Takemura, F., Hirokawa, K., Yoshiki, T., Tanaka, Y., Fujii, M., Kannagi, M.
(1999). Induction of Adult T-Cell Leukemia-Like Lymphoproliferative Disease and Its Inhibition by Adoptive Immunotherapy in T-Cell-Deficient Nude Rats Inoculated with Syngeneic Human T-Cell Leukemia Virus Type 1-Immortalized Cells. J. Virol.
73: 6031-6040
[Abstract]
[Full Text]
-
Jeffery, K. J. M., Usuku, K., Hall, S. E., Matsumoto, W., Taylor, G. P., Procter, J., Bunce, M., Ogg, G. S., Welsh, K. I., Weber, J. N., Lloyd, A. L., Nowak, M. A., Nagai, M., Kodama, D., Izumo, S., Osame, M., Bangham, C. R. M.
(1999). HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc. Natl. Acad. Sci. USA
96: 3848-3853
[Abstract]
[Full Text]
-
Kato, H., Koya, Y., Ohashi, T., Hanabuchi, S., Takemura, F., Fujii, M., Tsujimoto, H., Hasegawa, A., Kannagi, M.
(1998). Oral Administration of Human T-Cell Leukemia Virus Type 1 Induces Immune Unresponsiveness with Persistent Infection in Adult Rats. J. Virol.
72: 7289-7293
[Abstract]
[Full Text]
-
Hollsberg, P., Hafler, D. A.
(1993). Pathogenesis of Diseases Induced by Human Lymphotropic Virus Type I Infection. NEJM
328: 1173-1182
[Full Text]
Copyright © 1990 by the American Society for Microbiology. All rights reserved.